RIQUENT
La Jolla Pharmaceutical Company
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78102996 |
| Registration Number | 2787557 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | Mark I. Peroff |
| Attorney Docket Number | 1106.0011 |
| Law Office Assigned | M60 |
| Employee Name | DEFORD, JEFFREY S |
Timeline
| 2002-01-16 | Application Filed |
| 2002-09-10 | Published for Opposition |
| 2003-03-25 | Date of First Use |
| 2003-11-25 | Trademark Registered |
| 2003-12-01 | Location: FILE REPOSITORY (FRANCONIA) |
| 2010-07-03 | Cancelled |
| 2010-07-03 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  La Jolla Pharmaceutical Company |
| Address | 6455 Nancy Ridge Drive San Diego DE 92121 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2002-06-10 | 1 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-06-12 | 2 CNSA P: |
| NOTICE OF PUBLICATION | 2002-08-21 | 3 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2002-09-10 | 4 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2002-12-03 | 5 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2003-02-04 | 6 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2003-02-04 | 7 EXT1 S: |
| EXTENSION 1 GRANTED | 2003-02-04 | 8 EX1G S: |
| TEAS STATEMENT OF USE RECEIVED | 2003-05-13 | 9 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2003-05-13 | 10 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2003-08-12 | 11 SUPC I:Incoming Correspondence |
| CASE FILE IN TICRS | 2003-09-17 | 12 CFIT O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2003-09-23 | 13 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2003-09-29 | 14 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2003-11-25 | 15 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2010-07-03 | 16 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RIQUENT 78947249 3318222 Dead/Cancelled |
La Jolla Pharmaceutical Company 2006-08-08 |
 RIQUENT 78102996 2787557 Dead/Cancelled |
La Jolla Pharmaceutical Company 2002-01-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 